NYSE: INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
Market Cap
$1.23B
52w High
$147.03
52w Low
$38.91
P/E
9.33
Volume
823.45K
Outstanding Shares
28.81M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 67.15% over the last year. Revenue grew 8.94% over the trailing twelve months. Operating margin moved from 5.93% to 5.61%. Free cash flow grew 22.65% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently 5.61%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
11
Buy
16
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 3, 2026
Q3 FY26 · EPS est -$0.21 · Revenue est $194.84M
View